Tag Archives: APOE e4 (Apolipoprotein E e4)

Dementia Biomarkers Re-Explored? (General Psychiatry / JGCR)

Posted on June 17, 2019 by Dementia and Elderly Care News

Summary A recent systematic review examines biomarkers, as strictly defined, for neurodegenerative diseases. “Vast improvements in neuroimaging techniques have led to newly discovered biomarkers and diagnostics”. p.5 Behavioural biomarkers are mentioned hardly at all. Full Text Link Reference Maclin, JMA. … Continue reading →

Potential Association Between Tea Consumption and a Reduced Risk of Developing Dementia? (NHS Choices / Journal of Nutrition, Health and Aging)

Posted on April 23, 2017 by Dementia and Elderly Care News

Summary There is some evidence from Singapore that tea drinkers may be less likely to develop brain disorders such as dementia. Researchers discovered that Chinese elderly tea drinkers appeared to be less likely to develop dementia compared to non-drinkers. “The … Continue reading →

Posted in For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Nutrition, Quick Insights, Statistics, Universal Interest | Tagged Agency for Science Technology and Research, Alice Lim Memorial Fund, Alzheimer's Gene (APOE4 Gene), APOE e4 (Apolipoprotein E e4), Behind the Headlines, Biomedical Research Council, China, Chinese Elderly Tea Drinkers, Chinese Older Adults, Clinical Dementia Rating (CDR), Cognitive Benefits of Tea Drinking, Critical Appraisals, Department of Psychological Medicine: National University of Singapore, Epidemiology, Epidemiology and Statistics, Healthy Lifestyles, Journal of Nutrition Health and Aging, Lifestyle, Lifestyle Advice, Lifestyle Factors, Modified Mini-Mental State Examination (3-MS), National University Health System (Singapore), National University of Singapore, Neurocognitive Disorders, Neuroprotection Research, Neuroprotective Agents, Neuroprotective Lifestyles, Singapore, Singapore Longitudinal Ageing Studies (SLAS), Singapore Longitudinal Aging Study, Tea and Cognitive Health in Late Life, Tea Consumption, Tea Consumption and Dementia, Tea Drinking, Virtual Institute for the Study of Ageing, Yong Loo Lin School of Medicine: National University of Singapore | Leave a comment

On “SuperAgers”: People Who Avoid Age-Related Memory Problems (BBC News / Journal of Neuroscience / Journal of Cognitive Neuroscience / JINS)

Posted on September 14, 2016 by Dementia and Elderly Care News

Summary Researchers have been studying “SuperAgers”, and the associated phenomenon of SuperAging, to discover possible physiological and genetic mechanisms behind the fortuitous preservation of superior memory into old age. Full Text Link Reference ‘Super agers’ offer clue to keeping a … Continue reading →

Non-Alzheimer’s Dementias: Three Reviews (Lancet)

Posted on October 24, 2015 by Dementia and Elderly Care News

Summary The Lancet has published a series of three up-to-date reviews concerning non-Alzheimer’s dementia. Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access). Reference Dementia – not all about Alzheimer’s. [Editorial]. … Continue reading →

Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Posted on August 29, 2014 by Dementia and Elderly Care News

Summary This is an additional list of diagnostic testing-related protocols, further to the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Diagnostic Test Accuracy (DTA) protocols and protocol templates listed earlier in Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Models of Dementia Care, NIHR, Systematic Reviews, UK | Tagged 11C-PIB-PET, 18FDG-PET, 6-Item Cognitive Impairment Test (6-CIT), Abbreviated Mental Test (AMT), Addenbrooke's Cognitive Exaination-Revised (ACE-R), ALOIS: the Cochrane Dementia and Cognitive Improvement Group, APOE e4 (Apolipoprotein E e4), APOE-4 Allele, Asymptomatic Alzheimer’s Disease, Blessed Information-Memory-Concentration Test (Blessed I-M-C), Brain Imaging, Bristol University, Canada, CDCIG: Cochrane Dementia and Cognitive Improvement Group, Central and North West London NHS Foundation Trust, China, China Medical University, Clinical Cooperation Unit Nuclear Medicine (Heidelberg), Clock Drawing Test (CDT), Cochrane Dementia and Cognitive Improvement Group (CDCIG), Cochrane Diagnostic Test Accuracy (DTA) Dementia Reviews, Cochrane Diagnostic Test Accuracy (DTA) Reviews, Cochrane Diagnostic Test Accuracy Review Unit (DTA Unit), Cognitive Assessments / Screening Tools, CSF (Cerebrospinal Fluid Analysis of Amyloid Beta and Tau), CSF Tau, CSF Tau / ABeta Ratio, Department of Neurology: VU University Medical Centre Amsterdam, Devon, Diagnostic Test Accuracy (DTA) Handbook, Diagnostic Test Accuracy Reviews, Differential Diagnosis, Differential Diagnosis of Alzheimer’s Disease, Dopamine Transporter Imaging, Dopamine Transporter Imaging (for Diagnosis of DLB), DTA Handbook, Early Differential Diagnosis, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta: Neuroepidemiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, FP-CIT (Fluoropropyl-Carbomethoxy-3b-(4-Iodophenyl)Tropane), Frenchay Hospital (Bristol), Frontotemporal Dementia (FTD), Generic Protocols for Cross-Sectional and Delayed-Verification Studies, German Cancer Research Center: Medical PET Group - Biological Imaging, Germany, Glasgow Royal Infirmary, GP-Cog, Imaging, Imperial College London, Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), Institute of Cardiovascular and Medical Sciences: Glasgow, Institute of Cardiovascular and Medical Sciences: University of Glasgow, Institute of Health Research: Exeter, Institute of Public Health (Cambridge UK), Institute of Public Health (IPH), Institute of Public Health: Cambridge, IRCCS Fatebenefratelli (Brescia), Italy, John Radcliffe Hospital, LITA Polo Universitario, Maastricht University, Maastricht University: Department of Psychiatry and Neuropsychology, Mini-Cog, Modified Mini-Mental State Examination (3-MS), MRI, MRI Brain Imaging, MRI Scans, National Institute for Health Research (NIHR) Cochrane Collaboration Programme, Netherlands, Neuroimaging in Dementia Diagnosis, Neuropsychological Tests for Alzheimer’s Disease Diagnosis, Neuropsychological Tests for Dementia Diagnosis, North Bristol NHS Trust, Nuffield Department of Clinical Neurosciences (Oxford), Nuffield Department of Clinical Neurosciences: University of Oxford, Nuffield Department of Medicine (Oxford), Older People and Healthy Ageing Service Line (London), OPTIMA (Oxford Project to Investigate Memory and Ageing), OPTIMA (Oxfordshire UK), Ospedale Luigi Sacco, Oxford, Oxford Health NHS Foundation Trust, Oxford University Hospitals NHS Trust, Oxford University Medical School, PenCLAHRC, Peninsula CLAHRC, Peninsula Technology Assessment Group (PenTAG), PET-FDG (Positron Emission Tomography F-Fluorodeoxyglucose), PET-PiB (Positron Emission Tomography-Pittsburgh Compound B), Plasma and Cerebrospinal Fluid (CSF) Abeta42, Positron Emission Tomography (PET), Protocols, Public Health Epidemiology and Biostatistics: Birmingham, Queen's University (Canada), Radcliffe Department of Medicine, ratio, rCBF SPECT, Research Protocol, School for Mental Health and Neuroscience: Maastricht University, Shengjing Hospital, sMRI (Structural Magnetic Resonance Imaging), SPECT (Single Photon Emission Computed Tomography), St Louis University Mental Status Examination (SLUMS), Study Protocol, Sunnybrook Health Sciences Centre (Toronto), Systematic Reviews and Meta-Analyses, Test Your Memory (TYM), University Hospitals Bristol, University of Birmingham, University of Bristol, University of Cambridge, University of Exeter, University of Exeter Medical School, University of Glasgow, University of Milan, University of Oxford, University of Toronto, VU University (Netherlands), VU University Medical Centre | Leave a comment

Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia (Cochrane Database)

Posted on August 27, 2014 by Dementia and Elderly Care News

Summary The Cochrane Dementia and Cognitive Improvement Group (CDCIG) is working – in collaboration with the Cochrane Diagnostic Test Accuracy Review Unit (DTA Unit) and the Institute of Public Health (IPH) – on a series of Cochrane Diagnostic Test Accuracy … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, NIHR, Systematic Reviews, UK | Tagged 6-Item Cognitive Impairment Test (6-CIT), Abbreviated Mental Test (AMT), Addenbrooke's Cognitive Exaination-Revised (ACE-R), ALOIS: the Cochrane Dementia and Cognitive Improvement Group, APOE e4 (Apolipoprotein E e4), Asymptomatic Alzheimer’s Disease, Avon and Wiltshire Mental Health Partnership NHS Trust, Blessed Information-Memory-Concentration Test (Blessed I-M-C), Bristol, Bristol University: Academic Unit of Psychiatry, Bristol University: Addiction and Suicide Research, Bristol University: Centre for Mental Health, Bristol University: School of Community Medicine, CDCIG: Cochrane Dementia and Cognitive Improvement Group, Clock Drawing Test (CDT), Cochrane Dementia and Cognitive Improvement Group (CDCIG), Cochrane Dementia and Cognitive Improvement Group: Oxford University, Cochrane Diagnostic Test Accuracy (DTA) Dementia Reviews, Cochrane Diagnostic Test Accuracy (DTA) Reviews, Cochrane Diagnostic Test Accuracy Review Unit (DTA Unit), Cognitive Assessments / Screening Tools, CSF (Cerebrospinal Fluid Analysis of Amyloid Beta and Tau), Diagnostic Test Accuracy (DTA) Handbook, Diagnostic Test Accuracy Reviews, DTA Handbook, Exeter, FP-CIT (Fluoropropyl-Carbomethoxy-3b-(4-Iodophenyl)Tropane), Generic Protocols for Cross-Sectional and Delayed-Verification Studies, Glasgow, GP-Cog, Institute of Public Health (IPH), Institute of Public Health: Cambridge, Mini Mental State Examination (MMSE), Mini-Cog, Modified Mini-Mental State Examination (3-MS), Montreal Cognitive Assessment (MoCA), National Institute for Health Research (NIHR) Cochrane Collaboration Programme, Neuropsychological Tests for Alzheimer’s Disease Diagnosis, Neuropsychological Tests for Dementia Diagnosis, Oxford, Peninsula Technology Assessment Group (PenTAG), PET-FDG (Positron Emission Tomography F-Fluorodeoxyglucose), PET-PiB (Positron Emission Tomography-Pittsburgh Compound B), Protocols, Research Protocol, School of Community Medicine: Bristol University, School of Social and Community Medicine: Bristol University, Severn Deanery (Bristol UK), sMRI (Structural Magnetic Resonance Imaging), SPECT (Single Photon Emission Computed Tomography), St Louis University Mental Status Examination (SLUMS), Study Protocol, Systematic Reviews and Meta-Analyses, Test Your Memory (TYM), University of Bristol, University of Bristol: School of Social and Community Medicine, University of Cambridge, University of Cambridge: Department of Public Health and Primary Care: Cambridge, University of Exeter, University of Exeter Medical School, University of Glasgow, University of Oxford, University of Oxford: Radcliffe Department of Medicine | Leave a comment

Tag Archives: APOE e4 (Apolipoprotein E e4)

Dementia Biomarkers Re-Explored? (General Psychiatry / JGCR)

Potential Association Between Tea Consumption and a Reduced Risk of Developing Dementia? (NHS Choices / Journal of Nutrition, Health and Aging)

Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites